Porsche 911 (993) Carrera

The 993 Carrera is trading at a median of £46,500 in the UK market, down 6.1 percent over the past twelve months, though recent transaction data suggest the model has reached a floor after sustained pressure on values through 2023 and into 2024.

The sample of 18 transactions tracked over the past year represents moderate liquidity for the segment; the broader dataset of 77 total sales confirms consistent market activity, though not the velocity seen in hotter collectible categories. A single active listing at present indicates tight inventory, which typically constrains buyer choice but may provide some price support.

The 993 generation remains highly desirable despite its appreciating-classic status, backed by a production run of 38,626 units that ensures availability without saturation. Condition and specification—particularly IMS bearing history, service records, and whether examples are manual or automatic—remain primary drivers of individual value within the segment.

The cohort transacted in the past year averaged 40,637 miles, typical for examples now in their late twenties to early thirties; low-mileage examples command premiums, though most market participants accept these as user cars rather than investment vehicles locked in garages.

Base projections indicate further downward movement, with the median expected to decline to £40,275 by 2027 and £38,493 by 2029—declines of 13.4 and 17.2 percent respectively from current levels. This trajectory reflects maturing supply in the market and aging demographics, as early 990s 911s lose the novelty premium that first drove modern collectibility interest in the segment a decade ago.

Despite the negative three and five-year outlook, the combination of a bottomed-out status signal and a buy recommendation reflects valuation relative to replacement cost and the model's cultural anchor in Porsche lineage; entry-level collectors seeking authentic 1990s sports cars with user appeal may find near-term value at current asking prices, though patient buyers should expect continued softness over the medium term.